Section Arrow
CVM.NYSE-M
- Cel-Sci Corp
Quotes are at least 15-min delayed:2025/11/03 16:15 EST
After Hours
Last
 7.11
+0.02 (+0.28%)
Bid
6.91
Ask
7.25
High 7.11 
Low 7.09 
Volume 1911 
Regular Hours
Last
 7.09
0 (0.00%)
Day High 
7.41 
Prev. Close
7.09 
1-M High
10.83 
Volume 
65.91K 
Bid
6.91
Ask
7.25
Day Low
6.97 
Open
7.35 
1-M Low
6.06 
Market Cap 
56.67M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 8.47 
20-SMA 9.15 
50-SMA 9.64 
52-W High 32.7 
52-W Low 0.1912 
Exchange NYSE-M 
Valuation Estimation
EPS (Current/Estimated)
-9.13/-5.40
Enterprise Value
66.06M
Balance Sheet
Book Value Per Share
0.88
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
400.00K
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
PHIOPhio Pharmaceuticals Corp1.86-0.19-9.27%0.01PE
After Hours 1.77 -0.09 -4.84%
CRBUCaribou Biosciences2.4301+0.0101+0.42%-- 
After Hours 2.4 -- --
IOVAIovance Biotherapeutics1.95-0.02-1.02%-- 
After Hours 1.96 -- --
RXRXRecursion Pharmaceuticals5.43-0.09-1.63%-- 
After Hours 5.4487 -- --
THARTharimmune Inc.3.2+0.25+8.47%0.03PE
After Hours 3.1813 -0.0187 -0.58%
Quotes are at least 15-min delayed:2025/11/03 16:15 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development of the treatment of cancer and other diseases using the immune system. The Company's core capabilities include drug discovery, research, development, and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.